ONCOLYTICS BIOTECH INC (ONCY:NASDAQ)
$0.7688 -0.0112 (-1.4359%)
Analysed ONCOLYTICS BIOTECH INC (ONCY:NASDAQ) News Sources
Oncolytics Biotech® Announces Positive Preclinical Results Combining Pelareorep with a Pan-RAS Inhibitor in Colorectal Cancer
10-09-2026
yahoo.com
3 Clinical-Stage Cancer Stocks With Pristine Balance Sheets
16-09-2026
yahoo.com
ONCY Stock Heads For Sixth Straight Session Of Gains – Lead Therapy Shines in Early Combination Treatment Study
01-06-2026
stocktwits.com
ONCY: Seeking Registration Pathway for Part B of REO 033 Trial
16-07-2026
yahoo.com
From Ambrx to Oncolytics: Why Jared Kelly Believes the Market May Be Missing the Bigger Oncology Story
26-05-2026
yahoo.com
Oncolytics Biotech (ONCY) Valuation Check As New Pelareorep RAS Combo Data Draws Investor Attention
04-06-2026
yahoo.com
ONCY Stock Surged Today – Here’s What Securing A Key Immunotherapy Patent Means For Oncolytics
16-06-2026
stocktwits.com
Oncolytics Biotech Shares Climb Ahead of Planned FDA Meeting on REO 033 Trial (ONCY)
13-07-2026
advfn.com
Why Oncolytics Biotech Just Cleared A Hurdle That Stalls Most Cancer Trials
19-08-2026
yahoo.com
ONCY: FDA Provides Alignment on Registrational Pathway for Pelareorep in CRC
27-08-2026
yahoo.com
What is the current price of ONCOLYTICS BIOTECH INC (ONCY:NASDAQ)?
The current price of ONCOLYTICS BIOTECH INC (ONCY:NASDAQ) is $0.7688.
ONCOLYTICS BIOTECH INC (ONCY:NASDAQ) absolute price change since previous trading day?
The absolute price change of ONCOLYTICS BIOTECH INC (ONCY:NASDAQ) since the previous trading day is $-0.0112.
ONCOLYTICS BIOTECH INC (ONCY:NASDAQ) percentage price change since previous trading day?
The percentage price change of ONCOLYTICS BIOTECH INC (ONCY:NASDAQ) since the previous trading day is -1.4359%.
What is the most recent average sentiment score for ONCOLYTICS BIOTECH INC (ONCY:NASDAQ)?
The most recent average sentiment score for ONCOLYTICS BIOTECH INC (ONCY:NASDAQ) is 56 out of 100.
What is the most recent average sentiment for ONCOLYTICS BIOTECH INC (ONCY:NASDAQ)?
The most recent sentiment for ONCOLYTICS BIOTECH INC (ONCY:NASDAQ) is .
SEC-8K** Filing Available For ONCOLYTICS BIOTECH INC (ONCY:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.